1[1]Bosi Ferraz M, Evaluation of the 1982 ARA lupus criteria set in pediatric[J]. Clin Exp Rheumatol, 1994; 12 (1): 83～87
2[2]Cameron JS. Lupus nephritis in childhood and adolescence [J] . Pediatr-Nephrol, 1994;8(2) :230～249
3[3]Gloor JM. Lupus nephritis in children [J]. Lupus, 1998; 7 (9): 639～643
4[4]Niaudet P. Treatment of lupus nephritis in children [J]. Pediatr Nephrol, 2000; 14(2): 158～166
5[5]Iqbal S,Sber MR,Good RA, et al . Diversity in presenting manifestations of systemic lupus erythematosus in children[J]. J Peciatr,1999;135(3): 500～505
6[6]Massengill SF . Antiphospholipid antibodies in pediatric lupus nephri tis[J]. Am J Kidney Dis, 1997;29(3) :355～361
7[7]Niaudet P. Treatment of lupus nephritis in children[J]. Arch Pediatr,1999;6(12): 1312～1321
8[8]Lehman TJ, Onel K. Intermittent intravennous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus[J]. J Pediatr, 2000; 136(2 ): 243～247
9[9]Fu LW,Yang LY,Chen WP, et al . Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria[J]. Br J Rheumatol, 1998;37(2): 217～221
10[10]Jayne D. Non transplant uses of mycophenolate mofetil [J]. Curr Opin Nephrol Hypertens, 1999; 8 (5): 563～567
